Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial

European Archives of Psychiatry and Clinical Neuroscience

Volumn 240, Issue 1, 1990, Pages 1-4

  Maurer, M ^a   Henn, V ^b   Dittrich, A ^a   Hofmann, A ^b  

^a PSIN Psychologisches Institut für Beratung und Forschung   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Analgesia; Delta 9 tetrahydrocannabinol; Spasticity; Spinal cord injury

Indexed keywords

CODEINE; DRONABINOL;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG THERAPY; HUMAN; INJURY; MALE; ORAL DRUG ADMINISTRATION; PAIN; SPASTICITY; SPINAL CORD;

ADULT; CASE REPORT; DOUBLE-BLIND METHOD; EPENDYMOMA; HUMAN; MALE; NEUROLOGIC EXAMINATION; PAIN MEASUREMENT; PARAPARESIS, TROPICAL SPASTIC; PARESTHESIA; POSTOPERATIVE COMPLICATIONS; SPINAL CORD NEOPLASMS; TETRAHYDROCANNABINOL;

EID: 0025109126     PISSN: 0175758X     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/BF02190083     Document Type: Article

References (13)

1. An approach to the evaluation of drug effect during psychotherapy: a double-blind study of a single case
2. Statistical inference and the single case in clinical design
3. The perceived effects of marijuana on spinal cord injured males
4. Cannabis effect on spasticity in spinal cord injury
5. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis
6. The analgesic properties of delta-9-tetrahydrocannabinol
7. On the preparation of the indian hemp or gunjah (cannabis indica): the effects on the animal system in health and their utility in the treatment of tetanus and other convulsive diseases
8. Marihuana as a therapeutic agent for muscle spasm or spasticity
9. Treatment of human spasticity with delta-9-tetrahydrocannabinol